He noted, however, that the president and others need to look at all the different influences that affect prices, not
just drug companies.
I like him ok, but at the end of the day even most endo's know very little about diet and nutrition and are
just drug company sales people.
Not exact matches
The $ 1.1 billion Alphabet - backed Silicon Valley unicorn 23andMe
just pulled off a milestone feat: On Thursday, the Food and
Drug Administration (FDA) said the
company could sell its genetic tests and accompanying health risk reports for ten different diseases directly to consumers.
On average, the 30 large and small pharmaceutical and biotech
companies IDEA Pharma examined got
just 11 % of their 2017 revenue from
drugs developed within the past five years, says Mike Rea, the firm's CEO and one of the most insightful people I've met — no exaggeration — when it comes to pinpointing innovation choke points in the
drug industry.
That's particularly unfortuante for Cerecor seeing as CERC - 501 is the
company's lead
drug candidate — and the news comes
just days after Cerecor announced that a separate experimental depression
drug called CERC - 301 had also failed in the clinic.
When Sarepta Therapeutics nabbed a pioneering approval for a Duchenne muscular dystrophy (DMD)
drug last year, it won more than
just bragging rights and a controversial FDA approval: the firm also landed a coveted «priority review voucher,» which can either be sold off to another
company or used to slash the review period for a future Sarepta treatment.
Herper homes in on a relatively new class of super-powerful (and super expensive) cholesterol - busting
drugs called PCSK9 inhibitors (which were
just shown to reduce death from any cause, and particularly heart - related conditions), and how patients with staggeringly high cholesterol who would benefit from the treatments had to wrangle with insurance
companies that refused to cover them over their high prices.
But here's the problem for Valeant: According to its income statement, it spends
just 3 % of its revenue on R&D, compared to about 15 % to 20 % for large
drug companies.
It's possible that Paulson and Vanguard decided to invest their gains into other pharma
companies developing new
drugs, but they are
just as likely to put their money somewhere else.
But her underlying point isn't totally invalid — the furor over
drug price hikes like Mylan's is forcing legislators and private
companies alike to finally confront the issue head - on, and highlighting
just how difficult the disparate and largely opaque American medical financing system makes it to address these problems in a serious way.
By bringing a
drug that's been well - established as safe in other markets to the U.S. for the first time in order to treat a rare disease, the
company doesn't
just control its pricing destiny — it will also receive a coveted «priority review voucher» which it can hawk to another firm for tens (or even hundreds) of millions of dollars.
This is quite a big deal as Valeant bought Sprout Pharmaceuticals, the
company behind the
drug for a whopping $ 1 billion
just over two years ago.
More common and larger - scale cyber-attacks (from Sony pictures to Spanish renewable energy
companies) are yet another example of this unprecedented «communication» flow;
just as growth of the dark web has allowed for more effective connections in illegal activities —
drug trade, human trafficking, and the like.
In
just the past 14 months,
drug companies raised the prices of 20 prescription
drugs by 200 percent.
Earlier, a group at Bayer, a
drug company, managed to repeat
just a quarter of 67 similarly important papers.
Drug companies, they can't
just charge what they want.
2:53 pm ET: Cramer
just said that Facebook needs to do a better job of proactively hunting for bad content on Facebook, specifically that the
company needs to take down «illegal
drug sites» on the service.
Things got even better for Sprout a day after the F.D.A. approval, when Valeant Pharmaceuticals International, a
drug company whose deal - making acumen had made it a stock - market darling, bought Sprout for an astonishing $ 1 billion — twice its value
just two months earlier.
However, seeing a high number shouldn't be all that surprising, especially since almost half of the
companies the biotech fund holds don't even have a
drug on the market yet, so profits could be a long ways away — and this is
just the nature of the industry.
for stem cell research, there are tons of investors, it's
just that the
drug companies stand to lose millions and they have deeper pockets so they can bribe who they want to make sure it stays illegal.
And for stem cell research, there are tons of investors, it's
just that the
drug companies stand to lose millions and they have deeper pockets so they can bribe who they want to make sure it stays illegal.
it is integrated into many different sectors and may take
just as many forms — in the police force, the army, for corporate wellness (a service that provides
companies with health and exercise programmes for a healthier and more productive workforce), GP referral schemes, clinical research, health / life insurance
companies, in
drug companies, government agencies (i.e., Transport for London), nutrition and supplement
companies, office furniture (i.e., biomechanics and ergo - friendly furniture)?
There are many promising
drugs under development at life sciences
companies that have
just been waiting for a usable animal model.
For example, Swiss biotechnology
company Serono typically produces
just 400 grams per year of its recombinant multiple sclerosis
drug, Rebif.
«I was
just talking to a colleague the other day from a major
drug company who came in with a piece of paper with 15 bioinformatics jobs that they're ready to hire tomorrow,» he says.
The focus on innovation is
just as important for other types of biotechnology
companies, even ones that are not in the business of making
drugs.
Six are still being investigated, but so far, NIH has found
just one case in which rules were broken: that of a psychiatrist at Emory University in Atlanta who allegedly failed to report payments he received from
drug and device
companies.
A psychiatrist whose failure to disclose
drug company income contributed to a furor over conflicts of interest in biomedical research has
just received his first National Institutes of Health (NIH) grant in 3 years.
Harris cited other examples of concern — a review of 100 studies in the field of psychology in which the findings in only about a third of the studies were reproducible; an effort by scientists at Bayer, another large
drug company, that managed to reproduce the findings of only one - quarter of the studies under review; a
just - published review of 25 historical candidate genes for schizophrenia which found no evidence that the candidate genes are more associated with the disease than other genes.
Keith Mansford, who, until last year, was chairman of research in Britain at the
drugs company SmithKline Beecham, says: «Otherwise,
companies will suspejct it may
just be a ploy to put the onus back on industry — the government has told industry what to do and now it is up to industry to fund it.»
Two groups of researchers - one an academic team from Barcelona, Spain; the other a biotech
company from California called Sangamo - have
just announced successful experiments using zinc finger
drugs targeting the Huntington's disease gene.
Just recently a major
drug company got busted for «funding» research and deliberately keeping their involvement a secret from the publishers of the scientific journals the articles were being presented in.
It has only
just dawned on us that menstruation, pregnancy, and childbirth are not diseases; now we need to realize that menopause is not a disease despite millions in advertising dollars spent by
drug companies to convince us otherwise.
As a perfectly absurd example of how doctors have been wrongly influenced by the
drug companies... about 8 years ago, I was a perfectly healthy 28 year old, in great shape, exercising daily, eating a balanced healthy diet full of antioxidants and quality nutrition, no smoking, and with no real risk factors for heart disease, and
just because my cholesterol level has been consistently measured over 200 for my entire life, my doctor recommended I consider using a cholesterol lowering statin
drug.
Just in case you think this is a fringe point of view, here's a quote from an article in the January 2009 New York Review of Books titled,
Drug Companies & Doctors: A Story of Corruption by Marcia Angell:
Think how much
drug companies could make if they could
just sell sugar pills, but tell kids to take the fake pill with a cup of water.
Think how much
drug companies could make if they could sell sugar pills but
just tell kids to take the fake pill with... a glass of water.
Just because a multibillion - dollar
drug company produces a product, does not mean it is widely prescribed everywhere.
im
just a regular guy i work in a pharmacutical
company making
drugs and what not i prefer submission uhhhh what else?
For example, if you've decided to invest in the
drug industry, investing in several
companies rather than
just one can reduce the impact your portfolio might suffer from problems with any single
company.
And
drugs call the maker — my husband and I received Nexium for 2 years for free —
just be sure you write a note of appreciation: those notes go to someone and are used as data — I too work for a large
company!
The
company was listed as a big buy in many spots because of a positive meeting they
just had with the FDA in regards to the approval of their new
drug to treat Muscular Dystrophy.
Now there are a billion teenagers and they could
just as easily become child soldiers and
drug dealers as innovators and the owners of small
companies in favelas in Brazil.
If you replaced «IPCC» with «swine flu vaccine» you will have a very convincing argument that the vaccine was
just to line the pockets of multinational
drug companies.
Obviously it has centuries of «existing use» as the «status quo» energy source, but —
just as with any
drug company — as more and more evidence of the potentially harmful effects of its product emerge, it would seem that the responsibility of the governing authorities is to impose the precautionary principle and insist that the producers of the substance «prove» that it is harmless (in relation to alternatives).
Why, it's the Interior Department's Minerals Management Service, which was
just revealed by the department's inspector general to have engaged in
drug use, gifts, and illicit sex with oil
company executives.
This blog covers topics of interest to Food and
Drug Administration - regulated companies, fellow food and drug and health - care lawyers and regulatory personnel, as well as people just generally interested in FDA
Drug Administration - regulated
companies, fellow food and
drug and health - care lawyers and regulatory personnel, as well as people just generally interested in FDA
drug and health - care lawyers and regulatory personnel, as well as people
just generally interested in FDA law.
Mr. Ezrin represented
just under 100 Plaintiffs against Defendant Merck &
Company arising out of injuries associated with the defective
drug Vioxx.
Do pharmaceutical patents give life - sciences
companies an incentive to invest in creating life - saving
drugs, or do they
just keep their prices high?
Life insurance
companies aren't
just testing for illegal
drugs, but also for alcohol and tobacco use as well, you should know more about the life insurance
drug tests before applying for life insurance